Table 3 Dysfunctions associated with moderate-severe dyspnea after 12 months from discharge by COVID.
From: Neuroleptics used in critical COVID associated with moderate-severe dyspnea after hospital discharge
Parameter | No to mild dyspnea | Moderate-severe dyspnea | P Value |
|---|---|---|---|
Frailty (CFS score) | 3.00 (3.0–3.0) | 5.0 (4.0–5.0) | P < 0.01 |
Muscle Weakness (MRC score) | 56 (55-58.75) | 53 (46.5-56.25) | P = 0.01 |
EQ-5D (VAS) | 80 (80–90) | 70 (50-78.75) | P < 0.01 |
Depression (HADS score) | 8 (8-10.2) | 16 (14-18.35) | P < 0.01 |
Anxiety (HADS score) | 9.5 (8–12) | 14 (12–20) | P < 0.01 |
Repetitions during sit up 1 min test | 20 (18-22.5) | 13.5 (12-17.5) | P < 0.01 |
